Topic overview
Briefly
- Rep. Nicole Malliotakis criticized federally funded heroin injection sites in New York City, claiming they attract criminal activity.
- She wrote to U.S. Attorney General Todd Blanche, urging him to shut down these centers for violating federal law.
- Malliotakis's actions reflect a broader concern about drug policy and the need for long-term treatment solutions.
What happened
In New York City, Rep. Nicole Malliotakis, a Republican from New York, has been vocal against federally funded heroin injection sites operated by the nonprofit OnPoint. In an interview with Fox News Digital, she expressed concerns that these sites attract drug dealers and criminal activity, urging the Department of Justice to intervene. Malliotakis has taken her fight to the federal level by writing a letter to newly confirmed U.S. Attorney General Todd Blanche, requesting immediate action to close these centers, which she claims violate federal law under Title 21 of the United States Code Section 856.
Malliotakis highlighted that the Biden administration had approved a $2 million grant for these facilities, which she believes is an irresponsible use of taxpayer funds. She referenced an executive order signed by former President Donald Trump in July 2025, which redirected federal funding away from organizations that operate drug injection sites. This order was a significant step in her view, as it aimed to prevent federal resources from supporting what she termed as 'heroin shooting galleries.'
In addition to her letter, Malliotakis introduced a bill in 2025 aimed at defunding injection centers nationwide. She criticized the approach of New York's Democratic socialist Mayor Zohran Mamdani, who visited one of OnPoint's locations, arguing that such actions enable addiction rather than provide necessary support for recovery. Malliotakis emphasized the need for long-term treatment solutions instead of enabling environments for drug use.
The controversy surrounding these injection sites has sparked a broader debate about drug policy and public health in the United States. Malliotakis's stance reflects a growing concern among some lawmakers about the implications of harm reduction strategies, particularly in urban areas like New York City. As the situation develops, the response from the Department of Justice and the future of these facilities remain uncertain.
Comprehensive report
Full story,
in detail.
Trace the developments that led here, see how the story evolved, and understand the forces and wider context surrounding it.